The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
me change notification emails
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
Description of Modification
Revisions to the General Information and Proposal Preparation and Areas of Interest Documents.
Modification to Previous
Funding Opportunity Number:
Jan 30, 2009
Jul 19, 2011
Original Closing Date for Applications:
Mar 31, 2011
Current Closing Date for Applications:
Mar 31, 2011
Apr 30, 2011
Funding Instrument Type:
Category of Funding Activity:
Science and Technology and other Research and Development
Expected Number of Awards:
Estimated Total Program Funding:
Research on Chemical and Biological Defense
Cost Sharing or Matching Requirement:
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Dept. of the Army -- Space & Missle Defense Comman
Medical Chemical, Biological, Radiological and Nuclear (CBRN) countermeasures are an integral part of the U.S. Department of Defense (DoD) Chemical Biological Defense Program (CBDP) System of Systems approach that serves as the foundation and strength of the CBDP. The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is organized into eight Joint Project Management Offices, each responsible for specific commodity areas. The Chemical Biological Medical Systems Joint Project Management Office (CBMS JPMO) consists of the Joint Vaccine Acquisition Program (JVAP), Medical Identification and Treatment Systems (MITS), and Transformational Medical Technologies Initiative (TMTI) Joint Product Management Offices (JPMOs). The medical CBRN countermeasures developed by the CBMS JPMO directly support the current, near-term, and far-term challenges by providing the capability to prevent, diagnose and treat the effects of chemical, radiological and biological warfare agents. The JVAP JPMO provides biological protection by ensuring Warfighters’ immune systems are primed to protect them from selected threats. The MITS JPMO is responsible for the advanced development of U.S. Food and Drug Administration (FDA)-approved/licensed/cleared products for prophylaxis, treatment and diagnosis of CBRN agent exposure. The TMTI JPMO is developing and evaluating novel processes to accelerate the development and approval of medical CBRN countermeasures by leveraging lifecycle bioinformatics, enabling technologies, and other emerging technologies. General information on JPEO-CBD and subordinate JPMOs can be obtained from the JPEO-CBD website at http://www.jpeocbd.osd.mil/. This Broad Agency Announcement (BAA) is intended to solicit pre-proposals for: 1) those parts of development not related to the development of a specific system or hardware procurement in accordance with (i) the Federal Acquisition Regulation (FAR) 35.016(a) and (ii) DoD Grant Regulations (DoDGARs) subject to section 2374 of Title 10 United State Code and 2) the development of prototypes in accordance with Section 845 of Public Law (P.L.) 103-160. The purpose of this BAA is to identify the best available science, and as such, there are no set-asides associated with any awards resulting from this BAA. Specific areas of interest are described in the “Areas of Interest” attachment. As to any resultant procurement contracts, this BAA is issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), as implemented in the FAR at accordance. This Announcement provides a general description of CBMS JPMO’s project areas, including specific areas of interest, general information, evaluation and selection criteria, and proposal preparation instructions. All Attachments that are required with the submission of a full proposal are described in the Mandatory Proposal Forms section of this announcement. Proposals are sought from all eligible sources, including educational institutions, nonprofit organizations, and private industry. Generally, this announcement is continuously open; preliminary proposals (preproposals) may be submitted and will be evaluated at any time throughout the year. The availability of funds may limit the ability of the U.S. Government to make awards in specific areas, nevertheless preproposals are sought under this BAA announcement for all areas of interest described in the “Areas of Interest”. This announcement of the U.S. Government’s current interests will be posted on the Grants.gov web portal (http://www.grants.gov/), the Federal Business Opportunity website (http://www.fedbizopps.gov), the JPEO-CBD website (http://www.jpeocbd.osd.mil/ select current opportunities from the left side menu, then select Chemical Biological Medical Systems), and the USASMDC websit (http://www.smdc.army.mil/Contracts/Contracts.html) From time to time, this BAA may be amended with announcements or calls for proposals. Additionally, the application process may be amended as other electronic application processes are implemented. All amendments to this BAA will be announced on the JPEO-CBD website, the Grants.gov web portal, and the Federal Business Opportunity website. White papers pertaining to grant proposals should not be submitted prior to August 15, 2007.To facilitate communication on both scientific and administrative matters relating to this BAA, a single email address may be used for all communication with CBMS JPMO. Please send all technical and administrative questions and inquiries to email@example.com.Potential applicants are encouraged to discuss their proposal ideas with the CBMS technical staff. In addition to the address above, potential applicants may discuss their ideas with the Technical Contacts listed at the end of each area of interest.Administrative questions concerning the preparation of preproposals or proposals should be addressed to U.S. Army Space and Missile Defense Command (USASMDC)/CBMS JPMO Grants Officer. They should be emailed to firstname.lastname@example.org, faxed to 301-619-5069, ATTN: BAA 07-01, or mailed to the following address: Chemical Biological Medical Systems ATTN: BAA 07-01 64 Thomas Johnson Dr. Frederick, MD 21702Issues with submitting applications through the Grants.gov web portal should be directed to the Grants.gov help desk at 1-800-518-4726 or email email@example.com. The Contact Center hours of operation are Monday-Friday, 7 AM to 9 PM Eastern Standard Time.The Catalog of Federal Domestic Assistance (CFDA) can be accessed online at http://www.cfda.gov. The online CFDA provides access to a database of all Federal programs available to the grant community, including state, local and tribal Governments, academia and research institutions, commercial firms and not-for-profits. Included on the web site are contact information for the office that administers each program, instructions on how to apply for assistance, and several proposal writing guides. The CFDA number for this announcement is 12.360. This opportunity is being re-posted to add the new Adobe Application Package and to revise the areas of interest section. URL has been updated.
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.